EXTERNAL CIRCULAR 600-2006-16
FROM: DIRECTION OF MEDICINES AND BIOLOGICAL PRODUCTS
TO: SPONSORS / CONTRACT RESEARCH ORGANIZATIONS
SUBJECT: REPORT OF NATIONAL SERIOUS ADVERSE EVENTS ACCORDING TO CIRCULAR 600-1081-16
DATE: APRIL 11, 2016
Once the technical reasons have been resolved, it is reported that the report of serious national adverse events
It must be done from April 15, 2016, in accordance with what is established in the circular
600-1081-16 of February 18, 2016, through the format provided on the web and accessible through the following
link:
http: //soo.ql/forms/LyZ7pdN2nO
The password assigned for the report via web, continues in force for those reporters who have
requested, and for those who have not requested it, remember that it is obtained through presentation
staff in the Directorate of Biological Products and Products, with professionals from the Group of
Clinical Research, at the Chapinero headquarters of INVIMA.
Correct,
ELENA RANCO CHAPARRO
Directorate for Medicines and Biological Products
Project: I. Ordońez VoBo Legal: JP Santaella File: Circulates 2016
* 6 "'“' “” ““ ’’ ”'" ”
Bo'țj0łó - COÏØshîO